4.3 Article

Complete response of anaplastic pancreatic carcinoma to paclitaxel treatment selected by chemosensitivity testing

Journal

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
Volume 15, Issue 3, Pages 310-313

Publisher

SPRINGER TOKYO
DOI: 10.1007/s10147-010-0038-9

Keywords

Anaplastic carcinoma of the pancreas; Chemosensitivity testing; Paclitaxel; EUS-FNA

Categories

Ask authors/readers for more resources

A 58-year-old woman was admitted to our institute in June 2007 because of obstructive jaundice. A mass in the pancreatic head and multiple swollen lymph nodes surrounding the common hepatic artery were identified using computed tomography (CT). Subsequently, endoscopic ultrasonography-guided fine-needle aspiration biopsy (EUS-FNA) was done. Histopathologic results revealed anaplastic carcinoma of the pancreas. Using specimens obtained with EUS-FNA, chemosensitivity testing with adenosine triphosphate assay was performed. Testing indicated high chemosensitivity to paclitaxel (PTX). According to this result, chemotherapy using PTX was performed, and the primary lesion and lymph node metastases disappeared completely on CT. The patient has been doing well with no recurrence for 1 year and 11 months since initial chemotherapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available